Smartshoes zap freezing episodes in Parkinson's — pilot study launches
NCT ID NCT07001072
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tests whether a special shoe that vibrates can safely help people with Parkinson's disease who experience freezing of gait — a sudden inability to move their feet while walking. Twenty participants will wear the smartshoes and researchers will measure how well they tolerate the device and whether it reduces the time spent frozen. The goal is to see if this wearable, non-drug approach is worth studying further.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Smartshoes with haptic vibration feedback
What this could lead to
If it works, this could point toward a non-drug way to help people with Parkinson's walk more freely during freezing episodes.
What could go wrong
This is a very small pilot study (20 people) testing safety and tolerability first. The vibration feedback may not reduce freezing in practice, and results may not apply to all Parkinson's patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Stanford University
Palo Alto, California, 94305, United States